Mednow Releases Multiple Updates to Its IOS, Android and Web Based Applications, Including Pharmacist Led In-App Prescribing, Clinical Services Flows, and Single Sign-On for Seamless Patient and Partner Experiences
Mednow Inc. (OTCQX: MDNWF) has introduced new features in its virtual pharmacy applications, including the ability for Ontario pharmacists to assess and prescribe for 13 minor ailments as of January 1, 2023. This initiative, available through Mednow.ca and the Mednow Pharmacy App, allows patients with a valid Ontario health card to receive prescriptions at no cost, funded by the government. Additionally, the platform now offers single sign-on (SSO) capabilities for enterprise clients, enhancing user experience and enabling seamless integration of services. Medication reconciliations are also available through the Mednow platform, which aims to improve patient care and reduce healthcare costs.
- Introduction of pharmacist prescribing for 13 minor ailments increases accessibility to healthcare for Ontarians.
- New features include single sign-on capabilities, streamlining user experience for enterprise clients.
- Medication reconciliation services enhance patient safety and medication management.
- None.
-
Ontario pharmacists can now assess and prescribe for 13 minor ailments as ofJanuary 1, 2023 . This service will now be available directly via Mednow.ca and the Mednow Pharmacy App -
As part of the new update of the application,
Mednow also adds single sign-on capabilities -
Medication reconciliations are now also available via the
Mednow platform
"Mednow’s mission has always been to empower underutilized pharmacists and technology to improve the health of Canadians. We believe a pharmacist prescribing for minor ailments via mobile app is a perfect example," said Ali Reyhany, CEO and Co-Founder of
The Company also released single sign-on (SSO) for its enterprise clients through its
“We are beginning to see digital collaboration between stakeholders in pharmacy in
About
Neither
Cautionary Note Regarding Forward-Looking Statements:
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding the Company’s intention to use the SSO with patient care organizations and payors, is a forward-looking statement and contains forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release including that the Company will use the SSO with patient care organizations and payors. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, that the Company will not use the SSO with patient care organizations and payors as anticipated by management or at all. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005439/en/
Investor contact:
1-855-686-6300
ir@mednow.ca
Source:
FAQ
What new services has Mednow introduced as of January 1, 2023?
How can patients access Mednow's new services?
What benefits does medication reconciliation provide to Mednow patients?
What is the significance of single sign-on for Mednow?